about
From combinatorial peptide selection to drug prototype (II): targeting the epidermal growth factor receptor pathwayStructural basis for recognition of CD20 by therapeutic antibody RituximabStatins impair antitumor effects of rituximab by inducing conformational changes of CD20Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myelomaOverview of mimotopes and related strategies in tumor vaccine development.A differential cell capture assay for evaluating antibody interactions with cell surface targets.Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia.Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicityRelevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses.Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival.Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL.Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab.Role of rituximab in first-line treatment of chronic lymphocytic leukemia.De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: molecular mechanisms and correlation with rituximab sensitivitySynthesis and evaluation of multivalent branched HPMA copolymer-Fab' conjugates targeted to the B-cell antigen CD20.Association between polymorphism of CD20 gene and chronic lymphocytic leukemia in Chinese population.A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cellsIdentification of lanthanum-specific peptides for future recycling of rare earth elements from compact fluorescent lamps.B lymphocytes as therapeutic targets in systemic lupus erythematosus.Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure.Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential.Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndromeRefractory myasthenia gravis - clinical profile, comorbidities and response to rituximab.Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention.Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects.Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trial.Rituximab: modes of action, remaining dispute and future perspective.Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.Construction and characterization of a camelized, human, VH-based peptide vaccine against CD20 antigen.Anti-tumor activity of a B-cell receptor-targeted peptide in a novel disseminated lymphoma xenograft model.Assessment of microbiome variation during the perioperative period in liver transplant patients: a retrospective analysis.Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties.Novel pathomechanisms in inflammatory neuropathies.Advances in the management of skin cancer.
P2860
Q24621007-585C959A-792A-4595-B606-A69EFCECFB6EQ27644280-77AEB845-4469-4ACC-ACD5-4C6C171F588EQ28472420-5790913F-C064-4EA2-817F-4FDE633BE93CQ28731827-34526D11-2E86-43BF-A2D0-1B6BC6769411Q33389252-9B9A4CB7-7DCD-494B-80A5-7C8ADC147C06Q33533684-30F4DA8A-D727-4BD3-B56E-B3310819FE6BQ33876044-0C4C182A-4C76-453F-94F0-B0CE75FB64AEQ33878649-0BF5878B-870D-4827-AEF4-8E8855D38FB4Q33896738-738722FA-DBF3-47B2-9B3C-85028E34B56CQ33971785-FBC367AB-E0B8-4C5C-A957-A7873676BABDQ34147379-9BE055D0-5857-4083-A024-E049255E1890Q34334341-99EC7BC0-02F9-4BD6-8D1F-F1662AACC230Q34504860-44CAB953-4607-4F30-B4F0-A48621EF6B6EQ34574147-F9C349A9-5138-4745-9CA8-8D42892E3FB2Q35051741-315BC3C0-8CAA-4F5C-B572-D1442D18A553Q35104686-7B9D682D-0C9A-4B4F-99B4-48F0528FDD6FQ36046580-21C6FE57-0E59-42C6-B950-8CA9BBA29E00Q36216038-4E53275A-0AE4-48DD-9DEE-51D5A2ACABD8Q36227161-54A99EA9-773B-4F2A-BF8A-DA493F71DF91Q36653646-0FB5522D-78EE-4C89-8F44-A2DC570073BBQ36707550-C77E89E0-0DF0-403D-9B29-C85A77875C51Q37112898-556A701B-19DE-46E0-AF93-5662A845C872Q37212371-971AD49A-93CF-44BC-96AE-AEBD3311120BQ37275486-5DDE5474-0642-4929-9710-CEA4E2683FB5Q37344993-D1E3CB55-6B6B-4474-9B68-1DAF4F27F613Q37448352-8619C7B6-51CD-4017-A279-0B84317E12E0Q37586857-A4ED22BB-DA5A-4167-9F14-298EB948F4FEQ37613872-75539320-ED84-426E-842F-495D578D7BBEQ37934958-C6A5D69C-72E3-4B5C-AA48-9CD4D5123691Q38294619-346DBA7E-5F0C-403D-AC53-514387C66466Q38644355-8827DCFA-3ECD-4D87-81EE-057FF137E11EQ38807514-D7632D3E-32C3-446C-9F8E-75402BC004B7Q39193766-CFD67C2C-1765-45AA-9537-6A5751EFC4C1Q39467111-49817AFD-5DC9-487C-AE64-EEB6AA920E7AQ40098743-BB845A3A-670F-44B8-AD80-6BE7DDF4773BQ41966195-EBF4FC0B-85E8-42E8-B077-DEA7311F89D4Q47126672-A81A29D9-4DB3-4178-8B35-624BBCD5C8A1Q54456214-3182C848-6D70-468E-9B66-9DDC3D949CAF
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The epitope recognized by rituximab.
@ast
The epitope recognized by rituximab.
@en
type
label
The epitope recognized by rituximab.
@ast
The epitope recognized by rituximab.
@en
prefLabel
The epitope recognized by rituximab.
@ast
The epitope recognized by rituximab.
@en
P2093
P1433
P1476
The epitope recognized by rituximab.
@en
P2093
Florian Otto
Martin Trepel
Mascha Binder
Roland Mertelsmann
P304
P356
10.1182/BLOOD-2006-04-014639
P407
P577
2006-05-16T00:00:00Z